Branislava Milenkovic Selected Research

Branislava Milenkovic Research Topics

Disease

18	Chronic Obstructive Pulmonary Disease (COPD) 03/2023 - 10/2011
5	Asthma (Bronchial Asthma) 02/2024 - 12/2014
3	Bronchiectasis 04/2024 - 01/2016
3	Inflammation (Inflammations) 03/2023 - 10/2011
2	Emphysema 01/2018 - 01/2017
2	Hypoxia (Hypoxemia) 08/2014 - 11/2013
1	Pneumonia (Pneumonitis) 02/2023
1	Hypersensitivity (Allergy) 10/2021
1	Allergic Rhinitis 10/2021
1	Anaphylaxis (Anaphylactic Shock) 10/2021
1	Heart Failure 01/2021
1	Hypertension (High Blood Pressure) 01/2021
1	Chronic Bronchitis 01/2021
1	Sleep Initiation and Maintenance Disorders (Insomnia) 01/2021
1	Pain (Aches) 01/2020
1	Headache (Headaches) 01/2020
1	Airway Remodeling 01/2019
1	Rhinitis 01/2019
1	Dyspnea (Shortness of Breath) 10/2018
1	Pulmonary Atelectasis 01/2018
1	Cicatrix (Scar) 01/2018
1	Lung Diseases (Lung Disease) 01/2018
1	Postpericardiotomy Syndrome 01/2017
1	Acute Coronary Syndrome 01/2017
1	Interstitial Lung Diseases (Interstitial Lung Disease) 01/2016
1	Gastroesophageal Reflux (GERD) 01/2016
1	Osteoporosis 11/2013
1	Bone Resorption 11/2013
1	Myocardial Ischemia (Ischemic Heart Diseases) 10/2011
1	Hodgkin Disease (Hodgkin's Disease) 01/2007
1	Sarcoidosis (Schaumann Disease) 01/2007

Drug/Important Bio-Agent (IBA)

6	GoldIBA 03/2023 - 12/2015
5	Adrenal Cortex Hormones (Corticosteroids)IBA 02/2024 - 11/2013
3	EmbarcIBA 04/2024 - 01/2016
3	Biomarkers (Surrogate Marker)IBA 01/2024 - 01/2017
3	AdrenomedullinIBA 06/2015 - 02/2014
2	Matrix Metalloproteinase 9 (Gelatinase B)IBA 03/2023 - 11/2013
2	Tissue Inhibitor of Metalloproteinase-1IBA 03/2023 - 11/2013
2	Protease Inhibitors (Protease Inhibitor)IBA 03/2023 - 11/2013
2	Peptide Hydrolases (Proteases)FDA Link 03/2023 - 11/2013
2	Matrix Metalloproteinases (MMPs)IBA 03/2023 - 11/2013
2	Muscarinic AntagonistsIBA 01/2021 - 01/2018
2	CollagenIBA 10/2018 - 01/2017
2	Proteins (Proteins, Gene)FDA Link 01/2017 - 12/2015
2	proadrenomedullinIBA 06/2015 - 08/2014
2	C-Reactive ProteinIBA 11/2013 - 10/2011
1	Nitric Oxide (Nitrogen Monoxide)FDA Link 01/2024
1	Prostaglandins AIBA 01/2024
1	PeriostinIBA 01/2024
1	Immunoglobulin E (IgE)IBA 01/2024
1	Carbon MonoxideIBA 03/2023
1	Anti-Bacterial Agents (Antibiotics)IBA 02/2023
1	COVID-19 VaccinesIBA 10/2021
1	VaccinesIBA 01/2020
1	Theophylline (Theon)FDA LinkGeneric 01/2019
1	Hyaluronoglucosaminidase (Hyaluronidase)FDA Link 01/2019
1	EnzymesIBA 01/2019
1	Hyaluronic Acid (Hyaluronan)IBA 01/2019
1	prednylidene (Pred)IBA 01/2019
1	Collagen Type V (Type V Collagen)IBA 10/2018
1	Complement C5 (Complement 5)IBA 10/2018
1	Metalloproteases (Metalloproteinases)IBA 10/2018
1	Thrombin FDA Link 01/2018
1	Bronchodilator Agents (Bronchodilators)IBA 01/2018
1	Chondroitin Sulfates (Chondroitin Sulfate)IBA 01/2018
1	Fibrinogen (Factor I)FDA Link 01/2018
1	Lysine (L-Lysine)FDA Link 01/2018
1	SolutionsIBA 01/2018
1	ElastinIBA 01/2017
1	Non-Steroidal Anti-Inflammatory Agents (NSAIDs)IBA 01/2017
1	Complement C3 (C3 Complement)IBA 01/2017
1	SS-A antigen (Ro antigen)IBA 01/2016
1	AutoantibodiesIBA 01/2016
1	AcidsIBA 01/2016
1	Proton Pump InhibitorsIBA 01/2016
1	Mannose-Binding Lectin (Mannan-Binding Lectin)IBA 12/2015
1	beta-apocarotenoid-14',13'-dioxygenase (ADO)IBA 06/2015
1	Collagen Type I (Type I Collagen)IBA 11/2013
1	Tissue Inhibitor of MetalloproteinasesIBA 11/2013
1	Aryldialkylphosphatase (Paraoxonase)IBA 10/2011
1	Oxidants (Oxidizing Agents)IBA 10/2011
1	Superoxide DismutaseIBA 10/2011
1	AntioxidantsIBA 10/2011
1	Methotrexate (Mexate)FDA LinkGeneric 01/2007

Therapy/Procedure

8	Therapeutics 01/2024 - 12/2014
2	Pneumonectomy (Lung Volume Reduction) 01/2018 - 01/2017
1	Biological Therapy 01/2024
1	Injections 10/2021
1	Nebulizers and Vaporizers (Inhaler) 01/2019
1	Self Medication 01/2019
1	Radiotherapy 01/2007
1	ABVD protocol 01/2007
1	Drug Therapy (Chemotherapy) 01/2007
1	Aftercare (After-Treatment) 01/2007